Meeting
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
Authors
Jason Zhu
Duke University, Durham, NC
Jason Zhu, Sarabjot Pabla, Matthew Labriola, Rajan T. Gupta, Shannon McCall, Daniel J. George, Devin Dressman, Sean T. Glenn, Mary Nesline, Saby George, Carl Morrison, Tian Zhang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies
Sub Track
Biomarkers and Inflammatory Signatures
Citation
J Clin Oncol 37, 2019 (suppl 8; abstr 63)
DOI
10.1200/JCO.2019.37.8_suppl.63
Abstract #
63
Poster Bd #
D6
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
First Author: Jason Zhu
First Author: Ming Huang Chen
Poster
2016 Genitourinary Cancers Symposium
Integrated genomic correlates of response to PD-1 inhibitor nivolumab in metastatic renal cell carcinoma (mRCC).
First Author: Guillermo de Velasco
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.
First Author: Karam Ashouri